Submitted by ETC Staff on
RAFI's Annual Update on Terminator and Traitor
Communiqué number:
68
Terminator patent portfolios are changing hands because the Gene Giants are consolidating, spinning off, and selling agbiotech interests. New patents describing genetically modified plants with weakened immune systems that depend on the application of a chemical to regain their natural defenses against pests and disease are the most troubling examples of Traitor technology to date.
| Attachment | Size |
|---|---|
 Download File | 0 bytes |